ARCHIVES

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

This article is from The Cancer Letter archive.

Vol. 25 No. 20 | May 21, 1999

Download PDF Visit The Full Archive

Related Articles

Outside NIH, Applied Research Underfunded; Strong Federal Role Needed, Chabner Says

May 12, 1995

NCI New Advisory Group Named On special Populations

June 25, 1999

In Brief: Russos of Michigan Move To Fox Chase; Becker Named To Endowed Chair; NCI’s David Byar Dies

August 23, 1991

RFOs Available, Contract Awards, Sole Source Negotiations

February 3, 1978

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?

October 15, 2010